This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2018 Aug;19(8):e382.

doi: 10.1016/S1470-2045(18)30492-3.

Correction to Lancet Oncol 2018; 19: 953-64

No authors listed

PMID: 30102231
DOI: 10.1016/S1470-2045(18)30492-3

Published Erratum

Correction to Lancet Oncol 2018; 19: 953-64

No authors listed. Lancet Oncol. 2018 Aug.

. 2018 Aug;19(8):e382.

doi: 10.1016/S1470-2045(18)30492-3.

PMID: 30102231
DOI: 10.1016/S1470-2045(18)30492-3

No abstract available

PubMed Disclaimer

Erratum for

Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study.
Moreau P, Mateos MV, Berenson JR, Weisel K, Lazzaro A, Song K, Dimopoulos MA, Huang M, Zahlten-Kumeli A, Stewart AK. Moreau P, et al. Lancet Oncol. 2018 Jul;19(7):953-964. doi: 10.1016/S1470-2045(18)30354-1. Epub 2018 Jun 1. Lancet Oncol. 2018. PMID: 29866475 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations